About

Personalized Medicine in OncologyTM (PMO) is a peer-reviewed journal serving the informational needs of oncologists related to precision medicine and the next generation of oncologic care. The goal of PMO is to sensitize practitioners to the performance realities of new diagnostic and treatment discoveries and clarify molecular profiling technology as it relates to diagnostic, prognostic, and predictive medicine. Diagnostic and clinical treatment information concerning these 3 root aspects of personalized medicine in oncology is featured. PMO is the official publication of the Global Biomarkers Consortium and the World Cutaneous Malignancies Congress. GBC_logoHZ_22811WCMC logoHZ